1. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer

   • A. Valentino
   • P. Reclusa
   • C. Rolfo

   Review Article 04 January 2017 Pages: 651 - 657

   

2. Treating patients with ALK-rearranged non-small-cell lung cancer: mechanisms of resistance and strategies to overcome it

   • M. Drizou
   • E. A. Kotteas
   • N. Syrigos

   Review Article 04 January 2017 Pages: 658 - 666

3. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain

   • M. Hidalgo
   • R. Álvarez
   • Alfredo Carrato

   Special Article Open access 19 December 2016 Pages: 667 - 681

4. Peculiarities of the obese patient with cancer: a national consensus statement by the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology

   • P. Pérez-Segura
   • J. E. Palacio
   • A. Goday

   Special Article 10 January 2017 Pages: 682 - 694

   

5. miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC

   • L. Chang
   • K. Li
   • T. Guo

   Research Article 18 November 2016 Pages: 695 - 703

   

6. Role of axillary ultrasound, magnetic resonance imaging, and ultrasound-guided fine-needle aspiration biopsy in the preoperative triage of breast cancer patients

   • I. Barco
   • C. Chabrera
   • M. García Font

   Research Article 28 November 2016 Pages: 704 - 710

   

7. Neutrophil to lymphocyte ratio associated with prognosis of lung cancer

   • V. Bar-Ad
   • J. Palmer
   • C. Wang

   Research Article 01 December 2016 Pages: 711 - 717

   

8. High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab

   • S. S. Kumar
   • Y. Tomita
   • J. E. Hardingham

   Research Article 22 December 2016 Pages: 718 - 726

   

9. Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines

   • J. Capellades
   • P. Teixidor
   • C. Balana

   Research Article 22 December 2016 Pages: 727 - 734

   

10. A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma

    • W. Zhao
    • C. Sun
    • Z. Cui

    Research Article 19 January 2017 Pages: 735 - 741

    

11. The outcomes of radiotherapy and factors that predict overall survival in elderly patients with esophageal squamous cell carcinoma

    • H. Yin
    • M. E
    • C. Wang

    Research Article 13 January 2017 Pages: 742 - 749

12. Impact of clinicopathological parameters on survival after multiorgan resection among patients with T4 gastric carcinoma: a systematic review and meta-analysis

    • G. Zu
    • T. Zhang
    • X. Zhang

    Research Article 04 January 2017 Pages: 750 - 760

    

13. Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program

    • M. González-Cao
    • A. Arance
    • Spanish Melanoma Group

    Research Article 04 January 2017 Pages: 761 - 768

    

14. Activity of weekly paclitaxel−cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma: prognostic factors

    • I. Pajares Bernad
    • J. Martínez Trufero
    • A. Antón

    Research Article 24 January 2017 Pages: 769 - 776

    

15. Nasopharyngeal carcinoma: 30-year experience of a single institution in a non-endemic area

    • J. García-Lorenzo
    • N. Farre
    • X. León

    Research Article 24 January 2017 Pages: 777 - 783